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Can trainees perform Ahmed glaucoma
valve surgery as effectively as
attendings?
Melih Ustaoglu1,2, Hugh Huynh3, Sharmenie Esin3, Aakriti Garg Shukla1,
Reza Razeghinejad1
Abstract:
OBJECTIVE: To compare the surgical outcomes and early postoperative complications of Ahmed
glaucoma valve (AGV) implantation performed by residents with those performed by attending
physicians.
METHODS: This is a retrospective, case–control study. Data were gathered from chart reviews
of consecutive cases of AGV model FP7 implantation between January 2014 and July 2017.
Postoperative 1‑year results of patients who had at least 3 months follow‑up were evaluated.
RESULTS: One hundred and forty‑four eyes of 144 patients were included in this study: 72 patients
in the resident group, and 72 age‑ and sex‑matched patients in the attending group. Hyphema
and shallow anterior chamber were significantly more common in the resident group vs. attending
group (25% vs. 2.8% and 19.4% vs. 7.0%; P = 0.001 and P = 0.04, respectively). Neovascular
glaucoma (NVG) was more common in resident vs. attending group (30.6% vs. 1.4%; P < 0.001). No
significant difference in mean intraocular pressure (IOP) was found at any postoperative follow‑up
visits between the surgery groups (P > 0.05, for all). The number of postoperative visits within
3 months was similar between the groups (P = 0.84).
CONCLUSION: Resident‑performed AGV surgery lowered IOP, similar to attending‑performed
surgery. More frequent complications were observed in the resident group, which might be due to
the predominance of NVG in this group.
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A

hmed glaucoma valve (AGV; New World
Medical, Rancho Cucamonga, CA)
implantation is an effective procedure that
has been widely used in the surgical treatment
of glaucoma, particularly in refractory
cases requiring immediate intraocular
pressure (IOP) lowering.[1,2] The implantation
of AGV requires multiple complex maneuvers
by the primary surgeon, and surgeons early in
their training may face a steep learning curve
when performing this surgery.
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Resident surgical training in the United
States primarily focuses on cataract surgery,
with less emphasis on glaucoma tube
shunts and filtering procedures. Mean
phacoemulsification surgeries performed
by residents in the Accreditation Council
for Graduate Medical Education accredited
centers in 2014–2015 were 173.6 cases, while
mean glaucoma procedures performed by
residents were 4.5 for filtering procedures
and 6.7 for tube shunt surgeries.[3] The lack
of emphasis on glaucoma surgery may be
due to the expected complexity of tube
shunt implantation and variability in the
postoperative course. However, unlike
Baerveldt implant surgery, AGV surgery
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does not require placement of the plate under the rectus
muscles, insertion of a ripcord suture, occlusion with
a ligating suture, and thus may require fewer surgical
maneuvers. For these reasons, along with its proven
efficacy, the AGV may be the ideal tube surgery for
resident teaching.[4,5]
Given the rising numbers of glaucoma worldwide,[6] it
is crucial that current ophthalmology residents become
well‑versed in performing glaucoma surgery and
managing patients postoperatively. Prior studies have
evaluated resident‑performed AGV surgeries,[7‑9] but
have not compared outcomes of resident‑performed
AGV surgeries with those performed by attending
physicians. The purpose of this study was to compare the
short‑term success and early postoperative complication
rates of AGV surgery performed by residents and
attending physicians.

Methods
This retrospective case–control study was approved
by the Institutional Review Board of Wills Eye
Hospital (#19‑857E). Chart review was performed
on consecutive cases of standalone AGV model
FP7 implantation between January 2014 and July
2017. Informed consent was waived because of the
retrospective nature of the study.
All patients underwent classic fornix‑based conjunctival
peritomy AGV implantation with anterior chamber tube
placement as described by Coleman et al.[10] Topical
antibiotics were used four times a day for 1 week and
topical steroids were used four times a day for 1 week,
followed by a taper. Patients were classified into two
groups based on primary surgeon: the resident group
and the attending physician group. All resident cases
performed by second or 3rd‑year ophthalmology residents
and all surgeries were assisted by the fellowship‑trained
attending physicians. Inclusion criteria included at least
3 months of postoperative follow‑up and complete
documentation (including attending attestation at all
visits). A randomly selected equal number of surgeries
performed by fellowship‑trained attending physicians
during the same period were included. If both eyes of
the patients were eligible, only one eye was randomly
included in the study.
Demographic, preoperative, and postoperative clinical
information was collected from the electronic medical
record. Postoperative visit data were gathered from day
1, week 1, and months 1, 3, 6, and 12 after surgery. The
following information was recorded at each visit: visual
acuity (VA), IOP, and complications. VA was expressed
in logarithm of the minimum angle of resolution units.
Glaucoma medications were recorded at postoperative
32

months 3, 6, and 12. Additionally, the number of visits
within 3 months after surgery were recorded.
Hypotony was defined as IOP <6 mmHg detected
3 months or later after the surgery. Shallow anterior
chamber was defined as grade 1 (peripheral iridocorneal
touch) grade 2 (iris pupillary border corneal touch), and
grade 3 (lens or vitreous touch with the cornea).

Statistical analysis

Statistical analysis was performed using Statistical
Package for the Social Sciences (SPSS) for Windows
version 24.0 (SPSS, Inc., Chicago, IL, USA). For
continuous variables with a normal distribution,
the independent sample t‑tests were used, and the
Mann–Whitney test was used for nonparametric
variables. Chi‑square and Fisher’s exact tests were
used for categorical variables. P < 0.05 was considered
statistically significant.

Results
One hundred and forty‑four eyes of 144 patients
were included in this study: 72 patients in the
resident group, and 72 age‑ and sex‑matched patients
in the attending group. The mean follow‑up was
8.33 ± 3.64 (range = 3–12) months in the resident group
and 8.04 ± 3.73 (range = 3–12) months in attending
group. There were no statistically significant differences
in baseline demographics and characteristics between
the groups except for race and glaucoma type [Table 1].
African‑American descent was more common in the
resident than the attending group (59.7% vs. 19.4%,
respectively; P < 0.001). Neovascular glaucoma (NVG)
and primary open‑angle glaucoma (POAG) were
the most common glaucoma types in the resident
group (30.6% for both), while 50% of patients had
POAG in the attending group and only 1.4% had
NVG (P < 0.001).
Baseline and postoperative VA, IOP, and the number of
glaucoma medications are shown in Table 2. While the
mean baseline VA was lower in the resident than the
attending group (P = 0.03), this difference was not present
at any postoperative follow‑up visit (P ≥ 0.05 for all).
Baseline mean IOP was higher in the resident than the
attending group (31.2 ± 12.4 mmHg vs. 25.4 ± 8.9 mmHg;
P = 0.002), but this difference was not observed at any
postoperative follow‑up visit (P > 0.05 for all). The mean
baseline number of glaucoma medications was higher in
the resident group than the attending group (3.3 ± 1.1 vs.
2.9 ± 1.2, respectively; P = 0.02). There was no significant
difference between the groups for the number of
glaucoma medications at all postoperative follow‑up
visits. Trends of VA and IOP over time are demonstrated
in Figure 1a and b, respectively.
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Table 1: Demographic factors and type of glaucoma in resident‑ and attending‑performed surgery groups
Age (years)*
Sex†
Male
Female
Race†
White
African American
Hispanic
Asian
Others/not reported
Missing data
Glaucoma type†
Primary open‑angle
Chronic angle‑closure
Pseudoexfoliative
Pigmentary
Neovascular
Uveitic
Others
Lens status†
Phakic
Pseudophakic
Aphakic
Missing data

Resident group (n=72 patients), n (%)
64.4±16.5

Attending group (n=72 patients), n (%)
71.1±15.6

P
0.01

39 (54.2)
33 (45.8)

38 (52.8)
34 (47.2)

0.88

10 (13.9)
43 (59.7)
4 (5.6)
2 (2.8)
13 (18.0)
0

36 (50.0)
14 (19.4)
1 (1.4)
2 (2.8)
19 (26.4)
5 (6.9)

<0.001

22 (30.6)
12 (16.6)
0
0
22 (30.6)
10 (13.9)
6 (8.3)

40 (55.6)
15 (20.8)
2 (2.8)
1 (1.4)
1 (1.4)
5 (6.9)
8 (11.1)

<0.001

29 (40.2)
40 (55.6)
3 (4.2)
0

19 (26.4)
49 (68.0)
2 (2.8)
2 (2.8)

0.21

*The values are presented in mean±SD, †The values reported in parentheses are percentages. SD: Standard deviation

Table 2: Visual acuity, intraocular pressure, and
the number of glaucoma medications following
Ahmed glaucoma valve implantation in resident‑ and
attending‑performed surgery groups
Mean±SD

Visual acuity LogMAR
Preoperative (n=72/72)
Day‑1 (n=70/71)
Week‑1 (n=72/71)
Month‑1 (n=71/72)
Month‑3 (n=72/72)
Month‑6 (n=61/59)
Month‑12 (n=40/36)
Intraocular
pressure (mmHg)
Preoperative (n=72/72)
Day‑1 (n=70/71)
Week‑1 (n=72/71)
Month‑1 (n=71/72)
Month‑3 (n=72/72)
Month‑6 (n=61/59)
Month‑12 (n=40/36)
Glaucoma medication
Preoperative (n=72/72)
Month‑3 (n=72/72)
Month‑6 (n=61/59)
Month‑12 (n=40/36)

P

Resident
group

Attending
group

0.98±0.83
1.10±0.78
1.06±0.77
0.93±0.76
0.91±0.81
0.90±0.84
0.82±0.83

0.71±0.77
0.88±0.80
0.80±0.80
0.78±0.75
0.71±0.78
0.65±0.72
086±0.82

0.03
0.09
0.05
0.24
0.13
0.09
0.85

31.2±12.4
10.5±5.5
11.7±7.3
15.7±4.6
14.8±4.3
14.2±4.3
15.9±7.9

25.4±8.9
9.2±5.4
12.4±5.7
15.5±4.5
14.1±3.6
14.5±4.9
15.6±5.0

0.002
0.16
0.43
0.82
0.25
0.74
0.80

3.3±1.1
2.1±1.2
2.2±1.3
2.5±1.4

2.9±1.2
2.4±1.3
2.5±1.2
2.5±1.2

0.02
0.09
0.20
0.91

LogMAR: Logarithm of the minimum angle of resolution, SD: Standard
deviation

Complications of the AGV implantation are shown
in Table 3. Hyphema (25%) and shallow anterior
chamber (19.4%) were significantly more common in
the resident group than the attending group. The rates
of these complications were lower in the attending
group (hyphema 2.8%, P = 0.001 and shallow anterior
chamber 7.0%, P = 0.04). Five patients in the attending
group had grade 1 or 2 shallow anterior chamber and
all resolved with medical therapy. Two of 14 shallow
chambers in the resident group (2.7% of all patients
in the resident group) were grade 3 and underwent
anterior chamber reformation with viscoelastic agent.
Corneal transplantation was not required in either
group due to tube‑cornea touch during the follow‑up
period. Three eyes in the resident group with persistent
corneal edema and tube‑cornea touch underwent
tube revision with good visual outcomes requiring no
further intervention. Four eyes in the resident group
and one in the attending group with tube‑cornea touch
were managed conservatively as their vision remained
stable, and patients were asymptomatic. One patient
with choroidal effusion underwent choroidal effusion
drainage surgery, and the other patient improved with
medical therapy. None of the patients who experienced
diplopia needed surgical intervention.
The mean number of postoperative visits was 6.1 in the
resident versus 6.2 in the attending group (P = 0.84) in
the first 3 months after surgery.
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Discussion
This case–control study demonstrated that IOP,
VA, and the number of glaucoma medications in
resident‑performed AGV surgery was similar to that of
attending‑performed surgery. However, a higher rate
of postoperative complications including hyphema and
shallow anterior chamber was significantly more common
in the resident surgery group. Similar to previous studies,
proportions of African American patients[11,12] and NVG[9]
were higher in the resident surgery group.
Resident cases had higher preoperative IOP than
attending cases, yet had similar postoperative outcomes,
highlighting the ability of residents to successfully
carry out this procedure despite challenging baseline
circumstances. In resident cases, mean IOP decreased

a

b
Figure 1: Visual acuity (a) and intraocular pressure (b) profile over time following
Ahmed glaucoma valve surgery in the resident and attending groups

from 31.2 ± 12.4 mmHg to 10.5 ± 5.5 mmHg on
postoperative day 1 and remained below 16 mmHg
at all visits through postoperative month 12. Similar
results were also observed in the attending group in
our study; the mean IOP was 9.2 ± 5.43 mmHg at day 1
visit and remained below 16 mmHg at all visits through
postoperative month 12. These findings agree with that
of Desai et al., in which resident‑performed AGV surgery
led to a decrease in mean IOP from 30.8 ± 11.3 mmHg
to 15.3 ± 11.6 mmHg over a mean follow‑up period
of 34.7 ± 30.5 months (P < 0.001). [7] Another study
reported an IOP decrease from 28.8 ± 9.4 mmHg to
15.5 ± 7.6 mmHg following resident‑performed AGV
surgery at the 3 month postoperative follow‑up time
point. [8] Our results and those of the cited studies
demonstrate that desired IOP reduction can be achieved
following resident‑performed AGV surgeries.
Resident‑performed AGV surgery resulted in significantly
higher hyphema and shallow anterior chamber rates in
our study. The literature describes shallowing of the
anterior chamber angle configuration as a prominent
feature of NVG[13,14] and higher rates of hyphema are
seen following the tube shunt surgery of NVG cases,
as decompression of the eye can lead to bleeding.[15‑17]
The higher frequency of hyphema and shallow anterior
chamber was likely linked to the predominance of
complex glaucoma as evidenced by high proportion
of NVG and higher preoperative IOP in the resident
group as compared to attending group. The literature
describes variable complication rates were reported
following resident‑performed AGV surgery.[8,9] Hsia
et al. reported that the most common complications
following resident‑performed AGV surgery were
choroidal effusion (41%), hypotony (18%), and flat
anterior chamber requiring reformation (6.6%), all of
which were higher than rates in the present study.[8] The
rate of hyphema was lower than our study at 4.9%,[8]
which may be related to the lower proportion of NVG
cases (8% in Hsia et al. vs. 30.6% in the present study).[8] In
another study, Sharpe et al. reported that 55% of patients
had hyphema within the first postoperative week, and
26% of patients had choroidal effusion between months

Table 3: Postoperative complications of Ahmed glaucoma valve implantation in resident‑ and
attending‑performed surgery groups
Complications
Hyphema
Shallow anterior chamber
Tube‑cornea touch
Choroidal effusion
Diplopia
Bleb leak
Conjunctival wound dehiscence
Encapsulated bleb
Hypotony
34

Resident group (n=72 patients), n (%)
18 (25.0)
14 (19.4)
7 (9.7)
2 (2.8)
2 (2.8)
1 (1.4)
1 (1.4)
2 (2.8)
1 (1.4)

Attending group (n=72 patients), n (%)
2 (2.8)
5 (7.0)
1 (1.4)
0
0
0
4 (5.6)
0
1 (1.4)

P
0.001
0.04
0.06
0.49
0.49
1.00
0.36
0.49
1.00
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1 and 3, both of which were higher than rates seen in our
study.[9] Similar to the present study, the proportion of
NVG cases was high (41%), which may explain the higher
rates of hyphema seen in both studies. Accordingly, we
can theorize that differences in baseline characteristics
among varying patient populations may account for the
variability in types of complications.
Despite the higher rate of complications in the resident
group, the number of visits during the first 3 months
was similar in both groups. Although visits during
the first three postoperative months are included in
the surgical cost (during the “global period”), the
need for additional visits incurs more costs to patients
and the healthcare system. Data on the number of
visits has not been reported in prior evaluations of
postoperative costs to the academic institutions. Costs
related to the operating room, such as hours of operating
room utilization, have previously been included in
the evaluation of cataract surgery costs in previous
studies.[18,19] In addition to operating room related costs,
we believe that the number of follow‑up visits is also
a valuable parameter for glaucoma surgery, which
requires several more follow‑up visits than cataract
surgery.[20] The relative success of glaucoma surgery
also has an impact on the frequency of follow‑up visits.
A future study including operating room costs, patient
costs, postoperative interventions, and diagnostic tests in
a cost calculation would provide valuable information.
Limitations of this study include the unequal distributions
of glaucoma type and race between groups, which is
partially due to its retrospective nature. A prospective
study with a similar patient population could give us
more accurate results in this regard.

Conclusion
Although the resident performed cases had worse
disease at baseline (evidenced by higher mean IOP,
lower VA values, and higher number of medications),
12‑month outcomes among resident AGV cases
were similar to those of attending cases. Transient
complications including hyphema and shallow anterior
chamber were significantly higher in the resident group;
these may be related to the higher percentage of NVG
in this group. Including glaucoma procedures in the
resident surgical experience enables the next generation
of ophthalmologists to safely manage this complex
disease.
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